KR900003195A - 2'-메틸리덴피리미딘 뉴클레오시드 화합물, 그의 용도 및 제조방법 - Google Patents

2'-메틸리덴피리미딘 뉴클레오시드 화합물, 그의 용도 및 제조방법 Download PDF

Info

Publication number
KR900003195A
KR900003195A KR1019890012101A KR890012101A KR900003195A KR 900003195 A KR900003195 A KR 900003195A KR 1019890012101 A KR1019890012101 A KR 1019890012101A KR 890012101 A KR890012101 A KR 890012101A KR 900003195 A KR900003195 A KR 900003195A
Authority
KR
South Korea
Prior art keywords
carbon atoms
hydroxy group
alkyl
stands
compounds
Prior art date
Application number
KR1019890012101A
Other languages
English (en)
Other versions
KR0136869B1 (ko
Inventor
도오루 우에다
다쿠마 사사키
아키라 마쓰다
게이지 야마가미
아키히로 후지이
Original Assignee
하기와라 후미오
요시토미 세이야쿠 가부시키가이샤
하마구치 미치오
야마사 쇼유 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하기와라 후미오, 요시토미 세이야쿠 가부시키가이샤, 하마구치 미치오, 야마사 쇼유 가부시키가이샤 filed Critical 하기와라 후미오
Publication of KR900003195A publication Critical patent/KR900003195A/ko
Application granted granted Critical
Publication of KR0136869B1 publication Critical patent/KR0136869B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

내용 없음

Description

2'-메틸리덴피리미딘 뉴클레오시드 화합물, 그의 용도 및 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 하기 일반식(Ⅰ)로 표시되는 2'-메틸리덴피리미딘 뉴클레오시드 화합물 또는 그의 염.
    상기식에서, R1은 아미노 또는 히드록시기이고: R2는 할로겐 또는 저급알킬(R1이 아니노인 경우)이거나, 또는 R2는 탄소원자수 2-7의 알킬, 탄소원자수 2-4의 알키닐 또는 할로알킬(R1이 히드록시기인 경우)이며; R3는 수소 또는 인산잔기이다.
  2. 제1항에 있어서, 일반식(Ⅰ)내에서 R1이 히드록시기인 화합물의 토오토머인, 하기식으로 표시되는 화합물.
    상기식에서, R은 할로겐, 탄소원자수 2-4의 알킬, 탄소원자수 2-4의 알카닐 또는 할로알킬이고; R3는 수소 또는 인산잔기이다.
  3. 제1항에 있어서, 2'-데옥시-2'-메틸리덴-5-플루오로시티딘 또는 그의 염인 화합물.
  4. 활성성분으로서 제1항에서 정의한 화합물을 함유하는 것을 특징으로 하는 항암 조성물.
  5. 제4항에 있어서, 활성성분이 2'-데옥시-2'-메틸리덴-5-플루오로시티딘 또는 그의 염인 것을 특징으로 하는 항암 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890012101A 1988-08-25 1989-08-25 2'-메틸리덴피리미딘 뉴클레오시드 화합물, 그의 용도 및 제조방법 KR0136869B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63-212061 1988-08-25
JP21206188 1988-08-25

Publications (2)

Publication Number Publication Date
KR900003195A true KR900003195A (ko) 1990-03-26
KR0136869B1 KR0136869B1 (ko) 1998-04-25

Family

ID=16616219

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890012101A KR0136869B1 (ko) 1988-08-25 1989-08-25 2'-메틸리덴피리미딘 뉴클레오시드 화합물, 그의 용도 및 제조방법

Country Status (7)

Country Link
US (1) US5705630A (ko)
EP (2) EP0566162B1 (ko)
KR (1) KR0136869B1 (ko)
AT (2) ATE109154T1 (ko)
CA (1) CA1319685C (ko)
DE (2) DE68917060T2 (ko)
ES (1) ES2057031T3 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100481356B1 (ko) * 2002-10-17 2005-04-07 이수화학 주식회사 2'-ｏ-치환된 뉴클레오시드의 제조 방법

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020930D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Pharmaceutical combinations
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
US5665711A (en) * 1995-12-12 1997-09-09 Yoshitomi Pharmaceutical Industries, Ltd. Antitumor composition for oral administration
EP1270008B1 (en) * 2001-05-31 2006-07-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Fused tricyclic analogues of guanosine for treating tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE124702T1 (de) * 1987-03-19 1995-07-15 Yamasa Shoyu Kk 2'-alkyliden-pyrimidin-nukleosid-derivate, verfahren zur herstellung und verwendung.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100481356B1 (ko) * 2002-10-17 2005-04-07 이수화학 주식회사 2'-ｏ-치환된 뉴클레오시드의 제조 방법

Also Published As

Publication number Publication date
ATE109154T1 (de) 1994-08-15
EP0360018B1 (en) 1994-07-27
KR0136869B1 (ko) 1998-04-25
CA1319685C (en) 1993-06-29
EP0360018A1 (en) 1990-03-28
EP0566162A1 (en) 1993-10-20
DE68917060D1 (de) 1994-09-01
ATE154359T1 (de) 1997-06-15
DE68928127T2 (de) 1997-09-25
ES2057031T3 (es) 1994-10-16
EP0566162B1 (en) 1997-06-11
DE68928127D1 (de) 1997-07-17
US5705630A (en) 1998-01-06
DE68917060T2 (de) 1994-12-08

Similar Documents

Publication Publication Date Title
SE8804609D0 (sv) Adenosine derivatives
IL103301A0 (en) Pyrimidine nucleoside derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0275198A3 (en) Additive solution for blood preservation and activation
PH25859A (en) Composition for treatment of ischemic disorder
KR900003195A (ko) 2'-메틸리덴피리미딘 뉴클레오시드 화합물, 그의 용도 및 제조방법
KR920701120A (ko) 치환된 비시클로헵탄디온 유도체
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
ES8305730A1 (es) Un procedimiento para la preparacion de un derivado del imidazol.
ES468658A1 (es) Un procedimiento para preparar 4-alcohiltio-2-trifluorome- tilalcanosulfonanilidas y sus derivados
KR960700245A (ko) 메토트렉세이트 유도체[methotrexate derivative]
PL255643A1 (en) Method of obtaining 2-pyridinothiole derivatives
KR850005228A (ko) 살균제인 아미노알칸포스폰산 및 그 유도체
EP1057825A4 (en) ISOFLAVANE DERIVATIVES AND IMMUNOSTIMULATING COMPOSITIONS CONTAINING THEM
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
ES474230A1 (es) Procedimiento para preparar derivados de acido anilinoalco- hiltioico
KR840008012A (ko) 아미노에틸-피리딘 및 -피라진유도체의 제조방법
ES2061864T3 (es) Sustancia antitumoral, procedimiento para su preparacion, y agente anticanceroso que la contiene.
KR870001153A (ko) 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법
KR970061875A (ko) 신규 항바이러스성 6위치에 치환된 피리미딘디온 호모 카보사이클릭 뉴클레오시드 유도체 및 그의 제조 방법
ES467409A1 (es) Procedimiento de preparacion de derivados de la ajmalicina.
KR830004779A (ko) 2-메틸렌 숙신 아미드산을 활성 성분으로 함유하는 식물 생장조절용 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee